If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
18th Nov 20117:00 amRNSInterim Management Statement
11th Nov 20113:24 pmRNSAdditional Listing
11th Nov 20113:17 pmRNSDirector/PDMR Shareholding
1st Nov 20114:26 pmRNSTotal Voting Rights
1st Nov 20117:00 amRNSTransaction in Own Shares
31st Oct 20117:00 amRNSTransaction in Own Shares
28th Oct 20117:00 amRNSTransaction in Own Shares
20th Oct 20117:00 amRNSTransaction in Own Shares
19th Oct 20117:58 amRNSTransaction in Own Shares
12th Oct 20112:43 pmRNSScrip Dividend Alternative
7th Oct 20113:55 pmRNSDirector/PDMR Shareholding
6th Oct 20117:00 amRNSTransaction in Own Shares
5th Oct 20117:00 amRNSTransaction in Own Shares
4th Oct 20117:00 amRNSTransaction in Own Shares
3rd Oct 20112:05 pmRNSTotal Voting Rights
27th Sep 20117:00 amRNSTransaction in Own Shares
22nd Sep 20117:00 amRNSTransaction in Own Shares
21st Sep 20117:00 amRNSTransaction in Own Shares
20th Sep 20114:05 pmRNSDirector/PDMR Shareholding
15th Sep 201110:04 amRNSDirector/PDMR Shareholding
15th Sep 20117:00 amRNSTransaction in Own Shares
12th Sep 201112:00 pmRNSTransaction in Own Shares
8th Sep 20119:21 amRNSDirector/PDMR Shareholding
8th Sep 20117:00 amRNSTransaction in Own Shares
6th Sep 20119:45 amRNSTransaction in Own Shares
5th Sep 20117:00 amRNSTransaction in Own Shares
2nd Sep 20119:28 amRNSTotal Voting Rights
2nd Sep 20119:13 amRNSDirector/PDMR Shareholding
2nd Sep 20119:12 amRNSDirector/PDMR Shareholding
2nd Sep 20117:00 amRNSTransaction in Own Shares
31st Aug 20112:20 pmRNSDirector/PDMR Shareholding
31st Aug 201110:33 amRNSTransaction in Own Shares - Amendment
31st Aug 20117:00 amRNSTransaction in Own Shares
30th Aug 20119:06 amRNSShare Buy-back Programme
25th Aug 20117:00 amRNSInterim Results
3rd Aug 20117:00 amRNSNotice of Interim Results
1st Aug 201110:25 amRNSTotal Voting Rights
21st Jul 20117:00 amRNSTransaction in Own Shares
20th Jul 20117:00 amRNSTransaction in Own Shares
19th Jul 20115:25 pmRNSDirector's Other Directorships
19th Jul 20117:00 amRNSTransaction in Own Shares
18th Jul 20117:00 amRNSTransaction in Own Shares
7th Jul 201111:42 amRNSDirector/PDMR Shareholding
4th Jul 20113:04 pmRNSAdditional Listing
4th Jul 20117:00 amRNSTransaction in Own Shares
1st Jul 201112:17 pmRNSTotal Voting Rights
30th Jun 20117:00 amRNSShare Buy-Back Programme
29th Jun 20117:00 amRNSTransaction in Own Shares
24th Jun 20117:00 amRNSTransaction in Own Shares
23rd Jun 20117:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.